Thioglycolate-elicited macrophage cells treated with Kdo2-Lipid A (KLA) and compactin
Gene | Time course graph | Description | Treatment | 30min | 1h | 2h | 4h | 8h | 12h | 24h |
---|---|---|---|---|---|---|---|---|---|---|
Nsdhl | activated spleen cDNA, RIKEN full-length enriched library, clone:F830111P16 product:unclassifiable, full insert sequence [AK156993] | KLA | 1.01 | .89 | .83 | .82 | .83 | .88 | .84 | |
Compactin | .98 | 1.03 | .96 | .86 | 1.03 | .97 | .87 | |||
Compactin+KLA | .96 | .92 | .83 | .80 | .80 | .90 | .91 | |||
Nsdhl | NAD(P) dependent steroid dehydrogenase-like (Nsdhl), mRNA [NM_010941] | KLA | 1.00 | .96 | 1.06 | .94 | .83 | .85 | .99 | |
Compactin | 1.03 | .94 | 1.16 | 1.10 | .99 | 1.07 | 1.12 | |||
Compactin+KLA | 1.06 | .98 | 1.03 | .93 | 1.09 | .91 | 1.06 | |||
RAW 264.7 cells treated with Kdo2-Lipid A (KLA) and compactin
Gene | Time course graph | Description | Treatment | 30min | 1h | 2h | 4h | 8h | 12h | 24h |
---|---|---|---|---|---|---|---|---|---|---|
Nsdhl | activated spleen cDNA, RIKEN full-length enriched library, clone:F830111P16 product:unclassifiable, full insert sequence [AK156993] | KLA | 1.04 | .95 | .87 | .80 | .89 | .96 | .91 | |
Compactin | 1.03 | 1.01 | 1.04 | .98 | 1.08 | .95 | 1.04 | |||
Compactin+KLA | 1.08 | .93 | .93 | .84 | .86 | .88 | .95 | |||
Nsdhl | NAD(P) dependent steroid dehydrogenase-like (Nsdhl), mRNA [NM_010941] | KLA | 1.18 | 1.05 | 1.16 | .95 | .89 | .95 | .90 | |
Compactin | 1.13 | 1.09 | 1.08 | 1.23 | 1.16 | 1.06 | .78 | |||
Compactin+KLA | 1.12 | .99 | 1.12 | 1.03 | 1.19 | .95 | .97 | |||